Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $31.67 Consensus Target Price from Analysts
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average […]
More Stories
SecureWorks Corp. (NASDAQ:SCWX) Short Interest Down 33.4% in October
SecureWorks Corp. (NASDAQ:SCWX – Get Free Report) was the target of a significant drop in short interest in October. As...
SecureWorks Corp. (NASDAQ:SCWX) Short Interest Down 33.4% in October
SecureWorks Corp. (NASDAQ:SCWX – Get Free Report) was the target of a significant drop in short interest in October. As...
SLM Co. (NASDAQ:SLMBP) Short Interest Update
SLM Co. (NASDAQ:SLMBP – Get Free Report) was the recipient of a large drop in short interest in October. As...
SLM Co. (NASDAQ:SLMBP) Short Interest Update
SLM Co. (NASDAQ:SLMBP – Get Free Report) was the recipient of a large drop in short interest in October. As...
Short Interest in Red River Bancshares, Inc. (NASDAQ:RRBI) Rises By 46.1%
Red River Bancshares, Inc. (NASDAQ:RRBI – Get Free Report) was the recipient of a significant growth in short interest in...
Short Interest in Red River Bancshares, Inc. (NASDAQ:RRBI) Rises By 46.1%
Red River Bancshares, Inc. (NASDAQ:RRBI – Get Free Report) was the recipient of a significant growth in short interest in...